منابع مشابه
Therapeutic Interchange of Parenteral Anticoagulants: Challenges for Pharmacy and Therapeutics Committees
This is a review of key factors for pharmacy and therapeutics committees to consider when developing a therapeutic interchange (TI) program for venous thromboembolism (VTE) prophylaxis. Recent patient safety initiatives aimed at reducing the incidence of hospital-acquired VTE may increase the prescribing of thromboprophylactic agents recommended in VTE management guidelines. As a result, more p...
متن کاملParenteral anticoagulants in heart disease: Current status and perspectives (Section II)
Raffaele De Caterina1*; Steen Husted2*; Lars Wallentin3*; Felicita Andreotti4**; Harald Arnesen5**; Fedor Bachmann6**; Colin Baigent7**; Kurt Huber8**; Jørgen Jespersen9**; Steen Dalby Kristensen10**; Gregory Y. H. Lip11**; João Morais12**; Lars Hvilsted Rasmussen13**; Agneta Siegbahn14**; Freek W. A. Verheugt15**; Jeffrey I. Weitz16** 1Cardiovascular Division, Ospedale SS. Annunziata, G. d’Ann...
متن کاملParenteral Anticoagulants in Acute Coronary Syndromes and Interventional Cardiology: A Consensus Document.
GeorGe HaHalis1, Periklis Davlouros1, GriGorios TsiGkas1, emmanouel vavouranakis2, JoHn GouDevenos3, alexanDros D. TselePis3, DimiTrios C. alexoPoulos1; Task ForCe on THe manaGemenT oF ParenTeral anTiCoaGulaTion in aCuTe Coronary synDromes anD inTervenTional CarDioloGy oF THe insTiTuTe For THe sTuDy anD eDuCaTion on THrombosis anD anTiTHromboTiC THeraPy (i.s.e.T.a.T) 1University Hospital of Pat...
متن کاملDifferentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism
BACKGROUND The prevention of venous thromboembolism has been identified as a leading priority in hospital safety. Recommended parenteral anticoagulant agents with different indications for the prevention and treatment of venous thromboembolism include unfractionated heparin, low-molecular-weight heparins and fondaparinux. Prescribing decisions in venous thromboembolism management may seem compl...
متن کاملAn Overview of Novel Anticoagulants
Arterial and venous thromboembolism is one of the most common causes of death worldwide. For almost seventy years, heparin, low molecular weight heparin, and vitamin K antagonists have been widely used in the prevention and treatment of thromboembolic disorders. However, many of the limitations of these traditional anticoagulants have led to the search for and attempts to introduce better drug ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chest
سال: 2012
ISSN: 0012-3692
DOI: 10.1378/chest.11-2291